Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
gptkb:Gustaf_Salford
|
| gptkbp:country |
gptkb:Sweden
|
| gptkbp:focusesOn |
gptkb:cancer
neurosurgery radiation therapy |
| gptkbp:foundedBy |
gptkb:Lars_Leksell
|
| gptkbp:foundedYear |
1972
|
| gptkbp:headquartersLocation |
gptkb:Stockholm
|
| https://www.w3.org/2000/01/rdf-schema#label |
Elekta Instrument AB
|
| gptkbp:industry |
medical device
|
| gptkbp:numberOfEmployees |
approximately 4,700
|
| gptkbp:product |
gptkb:Gamma_Knife
linear accelerators oncology information systems brachytherapy systems |
| gptkbp:publiclyTraded |
yes
|
| gptkbp:revenue |
SEK 14.5 billion (2023)
|
| gptkbp:stockExchange |
gptkb:Nasdaq_Stockholm
|
| gptkbp:stockSymbol |
gptkb:EKTA-B
|
| gptkbp:website |
https://www.elekta.com/
|
| gptkbp:bfsParent |
gptkb:Elekta
|
| gptkbp:bfsLayer |
7
|